Antidote Technologies is a digital health company committed to accelerating medical research by transforming how patients and researchers connect. They build products that make it easier for individuals to find and participate in clinical trials, and for research sponsors and sites to reach and engage qualified, diverse patient populations. Antidote's core offering, Antidote Match™, is a clinical trial matching engine that powers patient portals for hundreds of patient advocacy groups, health websites, and research organizations. Their mission is to bridge the gap between patients seeking treatment options and researchers working on the next generation of medicines.
The New York headquarters serves as the primary center for strategic leadership, US business development, partnerships, and overall corporate governance. It also supports key technology and product development efforts.
Located in a prominent building in the Financial District, offering modern office spaces designed for collaboration and innovation, with easy access to transportation and city amenities.
Antidote fosters a mission-driven work culture focused on innovation, collaboration, and impact. Employees are passionate about leveraging technology to improve healthcare and accelerate medical breakthroughs. The environment is likely dynamic and fast-paced, typical of a growing tech company in the health sector.
The New York headquarters strategically positions Antidote within a major global hub for finance, technology, and healthcare, facilitating access to talent, investment, and key industry partners in the US.
Antidote Technologies operates with key offices in New York (USA) and London (UK), which serve as centers for its North American and European activities respectively. While its physical offices are concentrated, its digital platform and services for clinical trial matching have a global reach, connecting patients and researchers across numerous countries where clinical trials are conducted. Functions supported globally include technology platform development, data analytics, patient outreach strategies, and business development with international partners.
115 Broadway, Suite 1700
New York
NY
USA
Address: Fora, 21-33 Great Eastern Street, London, EC2A 3EJ, UK (This appears to be a flexible/co-working office space)
To drive growth and support for Antidote's clinical trial matching services across Europe, adapting to regional healthcare systems and patient needs.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Antidote' leadership includes:
Antidote has been backed by several prominent investors over the years, including:
Based on publicly available information, Antidote Technologies' executive team has remained largely stable over the past 12 months, with no major high-profile hires or departures announced. This suggests continuity in leadership and strategic direction.
Discover the tools Antidote uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Antidote Technologies likely utilizes a standard corporate email format. Based on common practices for technology companies of its size and domain name (antidote.me), the most probable formats include [first].[last]@antidote.me or [first_initial][last]@antidote.me.
[first].[last]@antidote.me
Format
jane.doe@antidote.me
Example
80%
Success rate
PR Newswire • 2023-10-18
Antidote Technologies and Sirona Dx announced a strategic partnership to streamline the identification and enrollment of eligible patients for precision medicine clinical trials. The collaboration aims to leverage Sirona Dx's advanced multiomic services with Antidote's patient matching platform....more
Antidote Blog • 2023-03-21
Antidote Technologies announced it has been awarded a Top Workplaces USA 2023 honor by Energage. This recognition is based solely on employee feedback gathered through a third-party survey....more
Business Wire • 2022-09-13
Antidote Technologies launched Antidote INSIGHTS, a new data product that provides researchers with aggregated, de-identified data on patient eligibility criteria and demographics. This tool is designed to help optimize clinical trial design for better patient centricity and recruitment....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Antidote, are just a search away.